Adis Journals
Browse
- No file added yet -

Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status

Download (174.68 kB)
Version 2 2022-05-12, 11:11
Version 1 2022-05-12, 10:41
media
posted on 2022-05-12, 11:11 authored by Adis Rapid Journals on behalf of:, Qing Huang, Kathleen L Deering, Qing Harshaw, Lori A Leslie

The above infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2022.

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    chemoimmunotherapychronic lymphocytic leukemiacytogeneticsibrutinibreal-world evidence

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC